Navigating a time-sensitive cell therapy supply chain during the coronavirus outbreak

Why established systems and relationships matter

Subscribe

Get updates from the Cell Lines Blog delivered to your inbox.

How HLA matching may help develop the next generation of cellular therapies

Advancements in Cell and Gene Therapy: 2019 Year-in-Review

Quality Starting Material: The Driving Force Behind Life-Saving Cell Therapies

By Jamie Margolis, PhD, SVP of Donor Services, NMDP/Be The Match®

Cell collection standards for cell therapies

A case study from the Standards Coordinating Body developed in partnership with Be The Match BioTherapies

How to overcome 3 common cell therapy supply chain disruptions

Design a tailored logistics plan to deliver

Overcoming challenges to cellular starting material collection

Q&A with the Be The Match BioTherapies Collection Network Liaison team

Driving CAR-T therapy safety and sustainability for the road ahead

Q&A with Abby McDonald, PhD, Solutions Development Supervisor

An opportunity to impact the future of medicine

As told by Leah, Be The Match BioTherapies® allogeneic donor